EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers

Gerrit Koopman, Tom Verhoeven, Petra Mooij, Roja F Acar, Thibault Harmand, Laney Flanagan, Jaco Bakker, Kinga P Böszörményi, Ronald E Bontrop, Jan A M Langermans, Hidde L Ploegh, Ernst J Verschoor und 3 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Gerrit Koopman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Primate Research Centre (BPRC), Rijswijk, Netherlands. Hauptthemen laut MEDLINE: COVID-19, Single-Domain Antibodies, SARS-CoV-2, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Virus Archive GLOBAL (EVA-GLOBAL), European Union's Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) impacts multiple anatomical sites. Whether this is due to the virus itself or is a secondary effect caused by the influx and activation of immune cells is not known. Positron emission tomography (PET) with immunoglobulins can provide insights into which sites and cells are activated in a living animal. Our aim is to use two nanobodies as tools to monitor (1) the distribution of antigen presenting cells (APC) by virtue of their Mafa‐DR expression profile, (2) virus‐infected cells and viral particles using a nanobody against the SARS‐CoV‐2 spike protein. Two [ 89 Zr]‐labeled nanobodies that target the SARS‐CoV‐2 spike protein and major histocompatability complex (MHC) class II antigens (Mafa‐DR), respectively, are used to monitor their distribution during an experimental SARS‐CoV‐2 infection in a nonhuman primate model. Scans are obtained before infection and on Day 3 and 10 post infection (pi) in two macaques each. The [ 89 Zr]anti‐SARS‐CoV‐2 spike nanobody localized to SARS‐CoV‐2‐associated lung lesions and the nasal mucosa, while the [ 89 Zr]anti‐human leukocyte antigen (HLA)‐DR nanobody was predominantly found in non‐affected lung tissue after infection. We also detected, pi, upregulation of the Mafa‐DR signal, indicative of recruitment of professional APCs, in the superior sagittal sinus. [ 89 Zr]‐labeled nanobodies show recruitment of macrophages/monocytes in non‐lesional lung tissue in cynomolgus macaques after experimental infection with SARS‐CoV‐2, as well as accumulation of the spike protein in both lung lesions and the nasal mucosa during infection. These results show the possibility of in vivo monitoring the quality and quantity of immune responses during the initial stages of an infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Single-Domain AntibodiesSARS-CoV-2Spike Glycoprotein, CoronavirusPositron-Emission TomographyAnimalsLungDisease Models, AnimalAntigen-Presenting CellsHumansMacaca fascicularis

Stichwörter der Autor:innen

COVID‐19PET‐CTSARS‐CoV‐2nanobodynonhuman primatesnuclear medicine

Substanzen

Single-Domain AntibodiesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Biomedical Primate Research Centre (BPRC), Rijswijk, Netherlands.
  • Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.
  • Cerberus Therapeutics, Cambridge, USA.
  • Department of Biology, Theoretical Biology and Bioinformatics, Utrecht University, Utrecht, Netherlands.
  • Department Population Health Sciences, Unit Animals in Science and Society, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Marieke A Stammes

Förderung

  • European Virus Archive GLOBAL (EVA-GLOBAL)
  • European Union's Horizon 2020

Zitieren

APA

Koopman, G., Verhoeven, T., Mooij, P., Acar, R. F., Harmand, T., Flanagan, L., Bakker, J., Böszörményi, K. P., Bontrop, R. E., Langermans, J. A. M., Ploegh, H. L., Verschoor, E. J., Vugts, D. J., Pishesha, N., & Stammes, M. A. (2024). Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers. Journal of Medical Virology. https://doi.org/10.1002/jmv.29956

Vancouver

Koopman G, Verhoeven T, Mooij P, Acar RF, Harmand T, Flanagan L, et al. Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers. Journal of Medical Virology. 2024. doi:10.1002/jmv.29956

BibTeX
@article{Koopman2024,
  author = {Koopman, Gerrit and Verhoeven, Tom and Mooij, Petra and Acar, Roja F and Harmand, Thibault and Flanagan, Laney and Bakker, Jaco and Böszörményi, Kinga P and Bontrop, Ronald E and Langermans, Jan A M and Ploegh, Hidde L and Verschoor, Ernst J and Vugts, Danielle J and Pishesha, Novalia and Stammes, Marieke A},
  title = {Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29956}
}
Kostenlos starten →